Cargando…

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease

Industrialized society-caused dysregular human behaviors and activities such as overworking, excessive dietary intake, and sleep deprivation lead to perturbations in the metabolism and the development of metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Hsu-Wen, Chao, Shi-Wei, Lin, Heng, Ku, Hui-Chen, Cheng, Ching-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359196/ https://www.ncbi.nlm.nih.gov/pubmed/30642126 http://dx.doi.org/10.3390/ijms20020298

Ejemplares similares

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
por: Yu, Cheng-Wei, et al.
Publicado: (2023)

Hydrogen sulphide in liver glucose/lipid metabolism and non‐alcoholic fatty liver disease
por: Mateus, Inês, et al.
Publicado: (2021)

Styrylpyrones from Phellinus linteus Mycelia Alleviate Non-Alcoholic Fatty Liver by Modulating Lipid and Glucose Metabolic Homeostasis in High-Fat and High-Fructose Diet-Fed Mice
por: Chiu, Chun-Hung, et al.
Publicado: (2022)

Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
por: Li, Ting, et al.
Publicado: (2019)

Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
por: Liao, Mingjuan, et al.
Publicado: (2022)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Novel glucose-lowering drugs for non-alcoholic fatty liver disease
por: Fu, Zuo-Di, et al.
Publicado: (2021)

Saponins of Tomato Extract Improve Non-Alcoholic Fatty Liver Disease by Regulating Oxidative Stress and Lipid Homeostasis
por: Yang, Ziming, et al.
Publicado: (2023)

Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease
por: Lekka, Evangelia, et al.
Publicado: (2022)

Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation
por: Ye, Jia-Hung, et al.
Publicado: (2016)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022)

Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease
por: Chen, Chien-Chih, et al.
Publicado: (2021)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice
por: Liu, Zhen-Shu, et al.
Publicado: (2022)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
por: Sun, Chao, et al.
Publicado: (2015)

Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease
por: Hsu, Jen-Ying, et al.
Publicado: (2018)

Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver
por: Li, Chao, et al.
Publicado: (2020)

Predictors of Impaired Glucose Regulation in Patients with Non-Alcoholic Fatty Liver Disease
por: Hatziagelaki, Erifili, et al.
Publicado: (2012)

Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease
por: Hung, Man-Chen, et al.
Publicado: (2020)

Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease
por: Liu, Hsien-Kuan, et al.
Publicado: (2019)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity
por: Hazer, İlhan, et al.
Publicado: (2020)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Gallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice
por: Chao, Jung, et al.
Publicado: (2014)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
por: Safari, Zahra, et al.
Publicado: (2023)

Lipid droplets maintain lipid homeostasis during anaphase for efficient cell separation in budding yeast
por: Yang, Po-Lin, et al.
Publicado: (2016)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease
por: Cheng, Yiping, et al.
Publicado: (2023)

PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
por: Cheng, Ching-Feng, et al.
Publicado: (2018)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
por: Yuan, Xian-Xian, et al.
Publicado: (2019)

Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease
por: Domingues, Inês, et al.
Publicado: (2023)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

Effects of exercise on high-fat diet–induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice
por: Huang, Wen-Ching, et al.
Publicado: (2022)

Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
por: Wang, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cgquieaq1nv9jluko09lr1q259